Related Experiment Video
Updated: Jun 20, 2026

Isolation of Pulmonary Artery Smooth Muscle Cells from Neonatal Mice
Published on: October 19, 2013
Changes in peroxisome proliferator-activated receptor-gamma activity in children with septic shock
Jennifer M Kaplan1, Alvin Denenberg, Marie Monaco
1Cincinnati Children's Hospital Medical Center, The University of Cincinnati College of Medicine, 3333 Burnet Avenue, MLC 2005, Cincinnati, OH 45229-3039, USA. Jennifer.Kaplan@cchmc.org
Insights
Sepsis alters peroxisome proliferator-activated receptor-gamma (PPARgamma) in critically ill children, affecting its activity and downstream targets like adipokines. These adipokines may serve as biomarkers for sepsis severity and outcomes.
Area of Science:
- Molecular biology
- Pediatric critical care
- Endocrinology
Background:
- Sepsis is a life-threatening condition in children characterized by a dysregulated host response to infection.
- Peroxisome proliferator-activated receptor-gamma (PPARgamma) is a nuclear receptor involved in inflammation and metabolism.
- Understanding molecular changes in sepsis is crucial for identifying new therapeutic targets.
Purpose of the Study:
- To evaluate changes in PPARgamma expression and activity in peripheral blood mononuclear cells (PBMC) of critically ill children with sepsis.
- To investigate the impact of sepsis on the PPARgamma ligand 15-deoxy-(12,14)-PGJ(2) (15d-PGJ(2)).
- To assess the levels of PPARgamma downstream targets, adiponectin and resistin, in pediatric sepsis.
Main Methods:
- A prospective case-control study was conducted in a single center.
- Involved critically ill children diagnosed with systemic inflammatory response syndrome, sepsis, or septic shock.
- Measured PPARgamma protein expression, activity, 15d-PGJ(2) levels, and plasma adipokines (adiponectin, resistin).
Main Results:
- PPARgamma activity was increased in PBMC of children with septic shock, despite decreased nuclear protein expression.
- PPARgamma activity correlated positively with the Pediatric Risk of Mortality (PRISM) score.
- Increased levels of 15d-PGJ(2), adiponectin, and resistin were observed in sepsis patients, with resistin levels higher in non-survivors.
Conclusions:
- Sepsis significantly alters PPARgamma expression and activity in pediatric patients.
- Plasma adipokines (adiponectin and resistin) show correlation with sepsis severity scores and mortality.
- Further research is warranted to elucidate the mechanisms of PPARgamma dysregulation in sepsis.
Purpose:
To assess changes in peroxisome proliferator-activated receptor-gamma (PPARgamma) in peripheral blood mononuclear cells (PBMC) from critically ill children with sepsis. Additionally, to investigate the effects of sepsis on the endogenous activator of PPARgamma, 15-deoxy-(12,14)-PGJ(2) (15d-PGJ(2)), and the downstream targets of PPARgamma activity, adiponectin and resistin.
Methods:
Single-center, prospective case-control study in critically ill children with systemic inflammatory response syndrome, sepsis or septic shock.
Results:
PPARgamma nuclear protein expression was decreased but PPARgamma activity was increased in PBMC from children with septic shock compared with controls. PPARgamma activity on day 1 was significantly higher in patients with higher pediatric risk of mortality (PRISM) score compared with controls [mean 0.22 optical density (OD) +/- standard error of the mean (SEM) 0.03 versus 0.12 OD +/- 0.02; p < 0.001]. Patients with resolved sepsis had increased levels of the endogenous PPARgamma ligand, 15d-PGJ(2), compared with patients with systemic inflammatory response syndrome (SIRS) and septic shock (77.7 +/- 21.7 versus 58 +/- 16.5 pg/ml; p = 0.03). Plasma high-molecular-weight adiponectin (HMWA) and resistin levels were increased in patients with septic shock on day 1 and were significantly higher in patients with higher PRISM scores. Nonsurvivors from sepsis had higher resistin levels on the first day of hospitalization compared with survivors from septic shock [660 ng/ml, interquartile range (IQR) 585-833 ng/ml versus 143 ng/ml, IQR 66-342 ng/ml; p < 0.05].
Conclusions:
Sepsis is associated with altered PPARgamma expression and activity in PBMC. Plasma adipokines correlate with risk of mortality scores in sepsis and may be useful biomarkers. Further studies are needed to understand the mechanisms underlying changes in PPARgamma in sepsis.
Related Concept Videos
Peroxisomes
GPCRs Regulate Adenylyl Cylase Activity
Two...
